Top Markets
#1 Black Phoenix Black Phoenix +820.83%
#2 Tutorial Tutorial +25.27%
#3 Beam Beam +25.04%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.53%
#5 MiL.k Alliance MiL.k Alliance +20.24%
#6 SAFEcoin SAFEcoin +18.55%
#7 Bless Bless +18.33%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +15.85%
#9 THORChain THORChain +15.63%
#10 Magma Finance Magma Finance +15.39%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Lin BioScience, Inc. Lin BioScience, Inc.

Lin BioScience, Inc.

6696
Classifica tra le azioni #5731
Lin BioScience, Inc. is an innovative biopharmaceutical company focused on... Lin BioScience, Inc. is an innovative biopharmaceutical company focused on developing novel therapies across oncology, ophthalmology, and metabolic diseases. Its robust pipeline includes LBS-008, an orally administered treatment currently in Phase 3 clinical trials for adolescent Stargardt disease (STGD1) and Phase 2/3 trials for dry age-related macular degeneration (Dry AMD), both aimed at evaluating its safety and effectiveness. Other key candidates are LBS-007, a natural non-ATP CDC7 inhibitor designed to combat various cancers; LBS-002, an anti-tubulin compound targeting primary and metastatic brain tumors; and LBS-009, an oral medication for non-alcoholic fatty liver disease and Type 2 diabetes. The company is headquartered in Taipei, Taiwan.
Prezzo delle azioni
$29.86
Ultima sincronizzazione: 2026-08-19
Capitalizzazione di mercato
$2.48B
Variazione (1 giorno)
4.92%
Variazione (1 anno)
502.82%
Paese
TW
Scambia Lin BioScience, Inc. (6696)

Categoria

Healthcare
Rapporto P/B per Lin BioScience, Inc. (6696)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Lin BioScience, Inc., il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Lin BioScience, Inc. da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH